73042-0201
DANYELZA
Naxitamab
INJECTION
Intravenous
NAXITAMAB
40.0
mg/10mL
73042-0201-01
1 VIAL, SINGLE-DOSE in 1 CARTON (73042-201-01) > 10 mL in 1 VIAL, SINGLE-DOSE
Nov. 25, 2020
Immunotherapy
Monoclonal Antibody
GD2
 
 
In Use